Akorn enters into supply agreement
BUFFALO GROVE - Akorn Inc., a specialty pharmaceutical company, and Bioniche Pharma have entered into a five-year commercial manufacturing and supply agreement for two undisclosed pharmaceutical products. Under the terms, Akorn will be responsible for the manufacturing and supply of the two injectable products. Expected launch for both products is in the second half of 2008.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.